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SUMMARY
The Janus-faced atracotoxins (J-ACTXs) are a family of insect-specific excitatory neurotoxins isolated from
the venom of Australian funnel-web spiders. In addition to a strikingly asymmetric distribution of charged
residues, from which their name is derived, these toxins contain an extremely rare vicinal disulfide bond. In
order to shed light on the mechanism of action of these toxins, and to enhance their utility as lead compounds
for insecticide development, we developed a recombinant expression system for the prototypic family
member, J-ACTX-Hv1c, and mapped the key functional residues using site-directed mutagenesis. An alanine
scan using a panel of 24 mutants provided the first complete map of the bioactive surface of a spider toxin,
and revealed that the entire J-ACTX-Hv1c pharmacophore is restricted to seven residues that form a
bipartite surface patch on one face of the toxin. However, the primary pharmacophore, or hot spot, is formed
by just five residues (Arg8, Pro9, Tyr31, and the Cys13–Cys14 vicinal disulfide). The Arg8–Tyr31 diad in
J-ACTX-Hv1c superimposes closely on the Lys–Tyr/Phe diad that is spatially conserved across a range of
structurally dissimilar K+ channel blockers, which leads us to speculate that the J-ACTXs might target an
invertebrate K+ channel.
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INTRODUCTION
As well as destroying an estimated 20–30% of the world’s food supply (1), arthropod pests are responsible
for the transmission of numerous human diseases. Mosquitoes, for example, transmit dengue fever, yellow
fever, West Nile virus, filariasis, and malaria, with the latter causing more than two million deaths annually
(2). These phytophagous and hematophagous insect pests have traditionally been controlled by spraying
broad-spectrum chemical pesticides. However, the emergence of insecticide-resistant insect populations
(3,4), as well as increasing concerns about the environmental and human health risks associated with certain
chemical pesticides (5,6), has stimulated the search for new pest-control strategies.
The pioneering work of Olivera and colleagues has revealed that the venoms of aquatic cone snails (Conus
spp.) are essentially highly evolved combinatorial peptide libraries (7,8). We have argued that spider
venoms can be analogously viewed as pre-optimized combinatorial libraries of insecticidal compounds (9),
and therefore we decided to exploit these venoms in the search for insect-specific peptide toxins. By
screening the venom of the lethal funnel-web spider Hadronyche versuta (10) we discovered three families
of insect-specific toxins (9,11,12), including an unusual family of excitatory neurotoxins that we named the
Janus-faced atracotoxins (J-ACTXs; see Fig. 1). In addition to being excellent biopesticide candidates, these
toxins have allowed validation of new insecticide targets, and consequently they should be invaluable leads
for the development of novel chemical insecticides (13).
In addition to a strikingly asymmetric distribution of charged residues, from which the toxin name is
derived, the J-ACTXs contain an extremely rare vicinal disulfide bridge (i.e, a disulfide bond between
adjacent cysteine residues) (12). The only other examples of proteins with vicinal disulfide bridges are
3
methanol dehydrogenase (14) and the α subunit of the acetylcholine receptor (15). In all three proteins, the
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vicinal disulfide bridge plays a key functional, rather than architectural, role; in the case of the J-ACTXs,
mutation of the disulfide bridge almost completely abrogates insecticidal activity (12). This led us to
speculate that the largely hydrophobic face of the toxin that encompasses the vicinal disulfide probably
represents its bioactive surface (12).
In this study, we developed an efficient recombinant expression system for J-ACTX-Hv1c, the most pernicious
and best characterized of the J-ACTXs (12,16), and used alanine scanning mutagenesis to determine the
bioactive surface of the molecule. We have localized the toxin pharmacophore to seven residues that form a
bipartite surface patch on one face of the toxin. However, we show that the primary pharmacophore is
formed by just five residues (Arg8, Pro9, Tyr31, and the Cys13–Cys14 vicinal disulfide) that we postulate form
a “hot spot” for target binding. A panel of follow-up mutations based on the alanine scan enabled us to
further define the chemical nature of the toxin pharmacophore, and it also provided unexpected clues about
the target of the J-ACTXs, which is presently unknown.
EXPERIMENTAL PROCEDURES
Construction of a Bacterial Overexpression System—A synthetic gene encoding J-ACTX-Hv1c was designed
by annealing, extension, and amplification of overlapping oligonucleotides (see Fig. 2). In the first step, four
oligonucleotides with codon usage optimized for maximal expression in Escherichia coli (J-Hv1c-1, J-Hv1c-2,
J-Hv1c-3, and J-Hv1c-R) were annealed and extended with polymerase. The four oligonucleotides were
added at a final concentration of 2 µM to 50 µl reaction buffer (10 mM KCl, 10 mM (NH4)2SO4, 20 mM
Tris-Cl (pH 8.75), 2 mM MgSO4, 0.1% Triton X-100, 100 mg ml
–1 BSA; Stratagene) containing 400 µM
dNTP mix (Life Technologies, Inc.). The annealing reaction was allowed to proceed for 30 min at 60 oC.
4
The temperature was then raised to 72 oC and the mixture was incubated for a further 30 min following
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addition of 2.5 U of Pfu polymerase (Stratagene). In the second step, 20 µl of the reaction mixture was used
as template for a standard PCR amplification of the entire coding sequence with primers J-Hv1c-F and
J-Hv1c-R. These primers encoded 5’-BamHI and 3’-EcoRI sites, respectively, for cloning purposes (see
Fig. 2). The amplified PCR product was digested with BamHI and EcoRI and subcloned into BamHI/EcoRI-
digested pGEX-2T vector (Amersham Pharmacia Biotech) using standard methods. The resulting plasmid
(pFM1) encodes J-ACTX-Hv1c as an in-frame fusion to the C-terminus of Schistosoma japonicum glutathione
S-transferase (GST) with an intervening thrombin cleavage site.
Single or double point mutations were introduced into the J-ACTX-Hv1c gene using PCR with pFM1 as the
template. Mutagenic primers incorporating the desired mutation proximal to the N- or C-terminus were used
with either J-Hv1c-L or J-Hv1c-R. Mutations in the central portion of the gene were incorporated using
complementary mutagenic primers followed by amplification with J-Hv1c-L and J-Hv1c-R.
Overexpression and Purification of J-ACTX-Hv1c and Mutants—E. coli BL21 cells were transformed with
pFM1—either in its original form or with one or more engineered point mutations—for overproduction of
GST-toxin fusion protein. Cells were grown in LB medium at 37 oC to an A600 of 0.6–0.8 before induction of
the fusion protein with 300 µM IPTG. The cells were harvested by centrifugation at an A600 of 1.9–2.1, and
then lysed by sonication. The recombinant fusion protein was purified from the soluble cell fraction using
affinity chromatography on GSH sepharose (Amersham Pharmacia Biotech) and then cleaved on the column
by addition of bovine thrombin (Sigma) (17). The liberated toxin was eluted from the column with Tris-buffered
saline (150 mM NaCl, 50 mM Tris, pH 8.0) and either: (i) purified immediately using reverse-phase (rp)
HPLC (see below), or (ii) dialyzed against water in 1-kDa cut-off dialysis tubing before being lyophilized.
5
Lyophilized toxin was then resuspended in 1 ml of 10 mM HCl prior to addition of 1 ml glutathione redox
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buffer (0.2 M Mops (pH 7.3), 0.4 M KCl, 2 mM EDTA, 4 mM reduced glutathione (GSH), and 2 mM
oxidized GSH). The toxin was then allowed to “fold” for 2–4 h before final rpHPLC purification.
The correctly folded recombinant toxin was then separated from non-native disulfide-bond isomers and
other contaminants by rp HPLC using a Vydac C18 analytical column (4.6 × 250 mm, 5 µm pore size). The
toxins were eluted from the column at a flow rate of  1 ml min–1 using a linear gradient of 15–22%
acetonitrile over 15 min. Correctly folded toxin eluted as the major peak with a retention time of 8–14 min
depending on the variant being purified. The toxin molecular weight was verified using electrospray mass
spectrometry.
CD Spectroscopy—CD spectra were recorded at 4 oC using a Jasco J-715 spectropolarimeter. Toxins
(25 µM) were dissolved in 1 mM sodium phosphate, pH 7.0 and loaded into a 0.1-cm rectangular quartz cell
for spectral analysis. Spectra were the average of 5–16 scans obtained using a scan rate of 20 nm min–1 and a
response time of 4 s. A blank spectrum consisting of buffer was run under identical conditions and subtracted
from each of the toxin spectra.
Insect Biological Toxicity Assays—Toxins diluted in insect saline (18) were injected into house flies (Musca
domestica) for quantitative determination of toxicity. Flies (9–20 mg, sex undetermined) were injected with
1–2 µl of toxin at concentrations of 10–106 pmol g–1. Experiments were performed in duplicate with a cohort
of ten flies for each toxin concentration. Control flies were injected with 2 µl insect saline. Dorsal thoracic
injections were dispensed with an Arnold microapplicator (Burkard Scientific Supply, Rickmansworth,
England) furnished with a 29-gauge needle. Flies were kept immobilized at 4 ˚C during all injections and
6
were subsequently transferred to room temperature (24 ˚C). LD50 values (i.e., the dose corresponding to 50%
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lethality of the test population at 24 h post-injection) were calculated from the dose-response data as
described previously (19).
RESULTS
Production of a Recombinant Expression System for J-ACTX-Hv1c—We attempted to develop an efficient
recombinant expression system for J-ACTX-Hv1c so that its key functional residues could be delineated
using site-directed mutagenesis. However, despite its small size (37 residues), J-ACTX-Hv1c contains eight
cysteine residues that can be paired in 105 different ways to form four disulfide bonds. Thus, expression of
the toxin in a foreign host necessitates consideration of how proper disulfide oxidation might be accomplished.
The thioredoxin and glutaredoxin disulfide-reducing pathways in Escherichia coli ensure that all cytoplasmic
cysteine residues, with a few notable exceptions (20), are in the reduced state (20,21). However, we recently
showed that expression of the insect-specific calcium channel blocker ω-ACTX-Hv1a (which contains three
disulfide bonds) as a GST-fusion protein in E. coli enables 65–70% of the soluble toxin to be recovered with
the correct disulfide framework (19). Since the yield of correctly folded toxin was not enhanced in a strain
with defective thioredoxin reductase (which should facilitate the formation of cytoplasmic disulfide bonds
(22)) we postulated that most, if not all, disulfide oxidation occurred after the cells had been lysed and the
fusion protein was exposed to the periplasmic Dsb system which normally catalyzes disulfide formation in
E. coli (23). We also reasoned (19) that active involvement of the Dsb system, in which DsbC catalyzes
disulfide isomerization, might explain why the yield of correctly folded recombinant ω-ACTX-Hv1a (65–70%)
is much higher than that obtained from in vitro folding of synthetic toxin (~15%) (24).
7
Given our previous success with ω-ACTX-Hv1a (19), we decided to develop a similar recombinant expression
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system for production of J-ACTX-Hv1c. We expressed J-ACTX-Hv1c in E. coli BL21 cells as a fusion to
the C-terminus of GST. SDS-PAGE analysis (Fig. 3A) revealed that the GST-toxin fusion protein was
efficiently expressed and predominantly soluble (compare lanes 1 and 2). Following cell lysis, the fusion
protein could be quantitatively bound to a GSH-agarose affinity column (compare lanes 3 and 4). On-column
thrombin cleavage (see lane5) liberated the recombinant toxin which could then be eluted from the column
with buffer.
The eluted toxin was either purified immediately using rpHPLC or incubated for 2–4 h in a GSH redox
buffer prior to rpHPLC purification. Correctly folded recombinant J-ACTX-Hv1c was always the major
peak in the rpHPLC chromatogram as verified by electrospray mass spectrometry and biological toxicity
assays (Fig. 3B). The yield of properly folded toxin in the eluate (as a percentage of total recombinant toxin
observed in the rpHPLC trace), was estimated from integration of the relevant HPLC peaks to be ~85%
(Fig. 3C). This is significantly higher than the yield of correctly-folded ω-ACTX-Hv1a (65–70%) that we
obtained previously using a similar GST-fusion expression system (19). This difference in percentage yield
was not unexpected given the in vitro folding properties of the two toxins: in vitro oxidation of chemically
synthesized J-ACTX-Hv1c and ω-ACTX-Hv1a in a GSH redox buffer gives yields of ~100% (12) and
~15% (24), respectively, of the native disulfide isomer.
 The yield of properly folded wild-type toxin was not increased by incubation of the lyophilized eluate for
2–4 h in a GSH redox buffer that promotes disulfide shuffling (25). However, for some of the point mutants,
incubation of the eluate in this buffer did increase the yield of properly folded toxin (data not shown). Thus,
coupling GST fusion-protein expression with an efficient disulfide-shuffling system provides us with an
8
efficient means of producing recombinant toxin with the correct disulfide framework.
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Alanine Scanning Mutagenesis of J-ACTX-Hv1c—The efficient recombinant expression system described
above allowed us to determine the functional relevance of almost every residue in J-ACTX-Hv1c using
alanine scanning mutagenesis. We previously demonstrated that deletion of the N-terminal residue (Ala1)
and the two C-terminal residues (Glu36 and Pro37) does not affect toxin function (16) and consequently the
scanning mutagenesis was restricted to residues 2–35. Residues Cys3, Cys10, Cys16, Cys17, Cys22, and Cys33
were excluded from the mutational analysis since their sidechains are involved in disulfide bonds which
form the cystine knot that is critical to the structure of the toxin (12). The two cysteine residues that form
the unusual vicinal disulfide (Cys13 and Cys14) were also excluded from the alanine scanning mutagenesis
since it was previously shown that the vicinal disulfide is critical for toxin function (12) and hence mutation
of either residue is certain to be highly deleterious. The remaining 22 non-alanine residues were mutated to
alanine, while the four alanine residues were mutated to serine.
All mutant toxins were successfully expressed as soluble GST fusion proteins except for the G5A and G19A
mutant proteins which proved to be completely insoluble as determined by SDS-PAGE analysis of soluble
and insoluble cell fractions (data not shown). Both Gly5 and Gly19 are located in β-turns where they are
necessary to achieve a sharp chain reversal (see Fig. 4 in ref. 12), and hence it is likely that the insolubility
of the G5A and G19A mutants results from impaired folding. Mutation of these residues was not pursued
any further, leaving us with an initial panel of 24 point mutants.
Alanine is generally chosen for scanning mutagenesis because it can be accommodated in most types of
secondary structure (β-sheet, α-helix, and β-turn), thus minimizing the chances that the point mutation will
9
induce major structural perturbations. Nevertheless, it is essential to check this experimentally. We did this
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by acquiring far-UV circular dichroic (CD) spectra of the native and mutant recombinant toxins. Since the
dominant structural element of J-ACTX-Hv1c is an antiparallel β-hairpin that protrudes from the globular
cystine-rich core, we anticipated that the CD spectrum would exhibit a typical β-sheet signature (minimum
at 210–216 nm; (26)), as observed previously for ω-ACTX-Hv1a (19). However, the CD spectrum of
recombinant J-ACTX-Hv1c displayed a maximum at 224 nm and a minimum at ~195 nm (Fig. 4A), which
is not typical of any one type of secondary structure. The spectrum is very different from that of unfolded
polypeptides which have no positive ellipticity and display a deep minimum  around 200 nm.
The CD spectrum of J-ACTX-Hv1c most closely resembles the β-turn spectrum derived from combined
analysis of Fourier transform infrared and CD spectra (27), which is consistent with the high β-turn content
of J-ACTX-Hv1c (43%). However, the single tyrosine residue in J-ACTX-Hv1c (Tyr31) most likely contributes
to the maximum at 224 nm, since a detailed analysis using model peptides revealed that tyrosine sidechains
have a significant positive CD band with a maximum around 225–230 nm (28). Consistent with this
hypothesis, we see a small loss of intensity of the positive CD band over the region 224–238 nm in a Y31A
mutant (Fig. 4A). We conclude that the small spectral changes observed for the Y31A mutant are due to loss
of the Tyr31 sidechain chromophore and not the result of a minor structural perturbation.
The CD spectra of 20 of the other 23 mutant toxins were essentially superimposable on the CD spectrum of
the native recombinant toxin (see examples in Fig. 4B), indicating that none of these mutations significantly
perturb the structure of the toxin (see Table I for a summary of the CD results). Two mutants, P9A and
R33A, caused minor changes in the CD spectrum that were suggestive of small structural perturbations
(Fig. 4C). In the case of R33A, the maximum was reduced in intensity and slightly blue-shifted from 224 to
10
220 nm. The P9A mutant caused a small reduction in intensity of the maximum without inducing a peak
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shift. The significance of these spectral changes is discussed in more detail below.
In striking contrast to the other 23 mutants, the A6S mutation caused a major structural perturbation, with
the CD spectrum (Fig. 4A) indicating that the mutant protein is largely unfolded. While it was not anticipated
that this point mutation would have such a dramatic effect on folding, similar results have been observed
during mutagenesis of other cystine-knot toxins. For example, during alanine scanning mutagenesis of the
N-type calcium channel blocker ω-conotoxin GVIA it was shown that less than 3% of G5A, N20A, and
T23A mutants were correctly folded (29). The A6S mutant was discarded from further analysis, leaving us
with a panel of 23 first-round mutants for biological assays.
Activity of Alanine-Scan Mutants—The insecticidal potency of each of the mutants was examined by
comparison of their LD50 values in house flies to that of unmutated recombinant toxin. As shown in Table I,
16 of the 23 mutants caused a 5-fold or lower increase in the LD50, and one of the mutants (P18A) caused a
marginal enhancement of insecticidal potency. We conclude that none of these 17 residues are critical to
toxin function. The I2A and V29A mutants caused 7-fold and 13-fold decreases in activity, respectively, and
we conclude that these residues are important but not absolutely critical for toxin function. The R33A
mutant caused an 11-fold decrease in insecticidal potency but the slightly perturbed CD spectrum of this
mutant precluded a definitive conclusion about its functional significance without further mutational analysis
(see below). Three mutants (R8A, P9A, and Y31A) caused very significant reductions in LD50 (98–270-fold)
and we conclude that these residues are critical for the insect-specific neurotoxic activity of J-ACTX-Hv1c.
Second-round Mutagenesis—The initial screen indicated that residues Arg8, Pro9, and Tyr31 are likely to be
11
key residues for the insecticidal activity of J-ACTX-Hv1c, with Ile2, Val29 and Arg33 being somewhat less
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important. In order to further probe the functional relevance of these residues, and to investigate the role of
individual chemical moieties in toxin activity, we designed a panel of additional mutants.
We first addressed the functional role of Arg33 because the R33A mutant toxin had a slightly perturbed CD
spectrum (Fig. 4C). We were concerned that the 11-fold decrease in insecticidal potency of the R33A
mutant might be due primarily to the structural perturbation induced by the mutation, rather than a consequence
of the change in chemical nature of the sidechain. We therefore constructed and analyzed R33L and R33H
mutations. Both mutants had wild-type CD spectra and caused less than 2-fold increase in the LD50 (see
Table I). Since at least one of these mutations (R33L) involves a radical change in the sidechain we
conclude that Arg33 is not a functionally important residue and that the loss in activity of the R33A mutant is
a consequence of an induced structural perturbation.
We next probed the features of Tyr31 that make this residue critical for toxin function. Mutation of this
residue to Ala caused a 162-fold decrease in insecticidal potency. The CD spectrum of a Y31F mutant
indicated that it was properly folded, and it displayed wild-type activity (Table I). We conclude that the
hydroxyl group is unimportant and that the aromatic ring is the key functional moeity of Tyr31.
Finally, we further probed the role of Arg8, the only functionally important charged residue, with an R8E
mutation. If Arg8 makes an ionic interaction with a negatively charged group on the target then we might
expect an R8E mutant to be even less potent than the R8A mutant because it will introduce repulsive
electrostatic interactions. The R8E mutant was properly folded as judged from its CD spectrum but its
activity was reduced a further 3-fold compared to the R8A mutant (see Table I). While a larger decrease in
12
potency might be expected from introduction of a repulsive electrostatic interaction with the toxin target, it
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should be noted that we are measuring the effect of the mutation on LD50 rather than target affinity. Previous
mutagenesis studies with the insecticidal neurotoxin LqhαIT showed that this tends to attenuate the effects
of the mutation; the decrease in target binding was typically 10–50-fold greater than the decrease in ED50 for
key functional residues (30). Our own studies with ω-ACTX-Hv1a have shown that, compared to binding
studies, the effect of the mutation can be attenuated by up to 40-fold in LD50 assays (H. W. Tedford, N.
Gilles, and G. F. K., unpublished data). Given this caveat, we tentatively conclude that Arg8 makes an
electrostatic interaction with a negatively charged moiety on the toxin target.
Functional significance of Pro9—The LD50 of a P9A mutant was found to be increased 270-fold compared
to the unmutated recombinant toxin (see Table I). However, the CD spectrum of this mutant was slightly
perturbed compared to the wild-type toxin (Fig. 4C), raising the possibility that the observed reduction in
insecticidal potency is due to an induced structural perturbation rather than loss of the proline side chain.
For example, it is plausible that mutation of Pro9 alters the conformation of the spatially proximal Arg8 and
Tyr31 residues, which we have demonstrated are crucial for toxin function. However, the perturbation of the
CD spectrum induced by the P9A mutation is relatively minor in that we observe only a slight reduction in
intensity of the maximum at 224 nm. This is inconsistent with a major conformational rearrangement, and
the minor changes in the positive CD band may be due largely to an increase in the solvent accessibility of
the nearby Tyr31 residue.
While the reduction in insecticidal potency caused by an R33A mutation does appear to be due to an
induced structural perturbation, the loss of potency is only 11-fold. In contrast, the P9A mutation caused a
25-fold greater loss of potency without perturbing the CD spectrum as much as the R33A mutant (see
13
Fig. 4C). This argues that much of the reduction in insecticidal potency in the P9A mutant is due to loss of
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the proline side chain rather than an induced structural perturbation. We therefore conclude that Pro9 is a
critical residue for toxin function.
The Vicinal Disulfide—We previously showed that deletion of the vicinal disulfide by isosteric substitution
of both Cys13 and Cys14 with Ser led to serious impairment of insecticidal activity (12), but the level of
impairment was not quantitated. In order to rank the functional importance of key toxin residues, we
examined the potency of a synthetically produced C13S,C14S mutant in M. domestica and showed that the
LD50 of this mutant was reduced 425-fold compared to the unmutated recombinant toxin. We previously
showed using NMR spectroscopy that this mutant assumes the native fold (12).
DISCUSSION
Insecticide design—The Janus-faced atracotoxins are a recently discovered family of insect-specific excitatory
neurotoxins (12). The presence of a functionally significant vicinal disulfide encompassed within a conserved
hydrophobic patch distinguishes these toxins from all other known members of the inhibitory cystine knot
motif family (31). These toxins are lethal to both phytophagous insects and various dipterans (12,16), but
they are inactive in vertebrates (12), making them valuable leads for the design of novel insecticides.
In order to elucidate the molecular mechanism of action of the Janus-faced atracotoxins, and to enhance
their utility as lead compounds for insecticide development, we developed a recombinant expression system
for J-ACTX-Hv1c and mapped the key functional residues using site-directed mutagenesis.  We constructed
and analyzed a total of 30 mutants (see Table I) which enabled us to explore the functional relevance of all
residues except Gly5, Ala6, and Gly19. This analysis revealed that Arg8, Pro9, Tyr31, as well as the vicinal
14
disulfide, are key functional residues, while Ile2 and Val29 are somewhat less important. These residues are
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conserved in all members of the J-ACTX family (see Fig. 1).
From an insecticide design viewpoint, there are two important conclusions that emerge from the mutagenesis
results: (i) the insecticidal potency of the Janus-faced atracotoxins appears to be conferred by a relatively
small number of residues. If the marginally important Ile2 and Val29 are excluded, only five of the 37
residues of J-ACTX-Hv1c appear to be critical for toxin function. Similar results have been obtained from
scanning mutagenesis of other cystine-rich toxins. For example, alanine scanning mutagenesis of the K+
channel blocker BgK revealed five key functional residues, of which three were deemed critical for channel
binding (32), and a similar number of functionally important residues were elucidated from mutagenesis of
the N-type calcium channel blockers ω-conotoxin GVIA (29) and ω-conotoxin MVIIA (33); (ii) the functionally
important residues identified from the mutagenesis studies are located on a single face of the toxin, where
they form two closely apposed patches on the surface of the protein (Fig. 5A,B). This distinguishes
J-ACTX-Hv1c from other cystine-rich toxins such as ω-conotoxin GVIA where functionally important
residues are found on multiple faces of the protein (29). Restriction of the pharmacophore to a single surface
of the toxin should increase the probability of designing functional small-molecule mimics of the toxin.
“Hot spot” versus “gasket” residues—The key functional residues revealed by the mutagenesis studies
(apart the vicinal disulfide) were Arg8, Pro9, and Tyr31. Arg and Tyr are two of the three most highly
enriched residues at the “hot spots” of protein-protein interfaces (only Trp is more common; (34)), which
leads us to speculate that these residues, along with the vicinal disulfide, form the primary binding site, or
hot spot, for interaction of J-ACTX-Hv1c with its target.
15
A recent survey of protein-protein binding interfaces (34) revealed that most interfaces consist of a central
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hot spot surrounded by residues whose primary role is to occlude water from the critical interacting residues;
in other words, these peripheral residues act like a gasket to seal off the hot spot from bulk solvent (34).
Remarkably, the exact chemical nature of the gasket residues appears to be relatively unimportant—alanine
is usually sufficient to provide a water-resistant seal (34). This might explain why mutation of Ile2 to Ala
caused only a 7-fold drop in activity (see Table I), whereas in a previous study (16) deletion of Ile2 led to a
substantial 70-fold drop in insecticidal potency. If Ile2 is a gasket residue then these results would be
expected since mutation of the residue to Ala would maintain the water-resistant seal, whereas complete
removal of this residue would expose the hot spot to bulk solvent and therefore significantly reduce target
binding and hence insecticidal potency. Given its location at the opposite end of the hot spot (see Fig. 5A,B),
Val29 might also be a gasket residue that helps to prevent bulk solvent penetrating into the binding site.
What is the target of the Janus-faced atracotoxins?—The three-dimensional fold of cystine-knot toxins
generally provides little insight into their mode of action—the cystine knot simply provides the structural
framework onto which diverse functional motifs can be grafted (13,31,35). However, for cystine-knot and
other disulfide-rich ion channel toxins, the topological disposition of key functional residues, regardless of
three-dimensional scaffold, is often informative of function. The classical example is the diad of Lys and
Tyr/Phe residues that is topologically conserved across a wide range of otherwise structurally dissimilar
potassium channel blockers (32). Thus, we wondered whether the topological arrangement of the J-ACTX-Hv1c
pharmacophore might provide some insight into the toxin’s mode of action.
Peptide toxins bind to voltage-gated sodium channels at a number of pharmacologically and apparently
topologically distinct sites; µ-conotoxins (CTXs) and δ-CTXs bind to sites 1 and 6, respectively, while
16
scorpion α-toxins and various sea anemone toxins bind to site 3 (36). Mutagenesis of µ-CTXs has revealed
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that the key residue for blockage of vertebrate voltage-gated sodium channels is an arginine (Arg13 in µ-CTX
GIIIA) that projects into the pore of the channel (37,38). However, in striking contrast to J-ACTX-Hv1c, the
critical arginine is surrounded by an array of positively charged residues (Arg1, Lys11, Lys16, and Arg19 in
µ-CTX GIIIA) that also interact with the channel according to mutant cycle analyses (39). While scorpion
α-toxins bind to a different locus on sodium channels than µ-CTXs, their bioactive surface also comprises a
critical positive residue (Lys8 in the insecticidal scorpion α-toxin LqhαIT) surrounded by several other
important positively charged residues (30). The bioactive surface of the sea anemone toxins appears to be
more chemically diversified, with both positively and negatively charged residues as well as hydrophobes
being important for channel binding (40,41). Thus, if J-ACTX-Hv1c interacts with sodium channels, it must
do so in an entirely different manner to the µ-CTXs, sea anemone toxins, and scorpion α-toxins.
N- and P/Q-type voltage-gated calcium channels are usually distinguished by their susceptibility to blockage
by ω-CTXs and ω-agatoxins, respectively. At this stage, the residues responsible for interaction of ω-agatoxins
with P/Q-type channels have not been identified. However, mutagenesis studies have revealed that N-type
calcium blockers such s ω-CTX GVIA (29), ω-CTX MVIIA (33), and Ptu1 (42) contain a functionally
critical Lys–Tyr diad. The lysine, but not the tyrosine, residue is conserved in the recently discovered L-type
calcium channel blocker ω-CTX TxVII (43). The Lys and Tyr residues in the N-blocker diad are separated
by a considerable distance and are located on opposite faces of the toxin (see Fig. 8 in ref. 29); this diad
bears no resemblance to the J-ACTX-Hv1c pharmacophore. In any case, blockage of calcium channels is
inconsistent with the excitatory phenotype induced in insects by J-ACTX-Hv1c (12).
Intriguingly, the functionally critical Arg8 and Tyr31 residues in J-ACTX-Hv1c align extremely well with the
17
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agitoxin2 (Fig. 5C). Similar overlays (not shown) can be made with the functionally critical diad residues in
numerous other K+ channel blockers such as charybdotoxin (44) and κ-conotoxin PVIIA (45). Thus, although
the three-dimensional fold of J-ACTX-Hv1c is homologous to the sodium channel modulators conotoxin
GS, µ-agatoxin-I, and δ-ACTX-Hv1a (12), the hot spot identified by site-directed mutagenesis provides
circumstantial evidence that the J-ACTXs might target invertebrate K+ channels. The excitatory phenotype
induced by the J-ACTXs in Drosophila melanogaster (F. M., R. A. Reenan, and G. F .K., unpublished
observations) and other insects (12) is consistent with a potassium channel blocking activity. Indeed, prior
to death, the fruit flies exhibit a leg-shaking phenotype which is reminiscent of that induced by conditional
mutants of Drosophila K+ channels such as EAG and Shaker (46).
Thus, the topological arrangement of key functional residues, rather than the three-dimensional structure per
se, allows us to speculate that the J-ACTXs target invertebrate K+ channels. We plan to test this hypothesis
by employing a variety of biochemical, electrophysiological, and genetic screens in order to identify the
exact molecular target of these toxins.
Mode of target recognition—Regardless of the molecular nature of the target of the J-ACTXs, the mutagenesis
studies allow us to make some concrete conclusions about the types of interactions that must occur between
the toxin and its target (Fig. 5B). This data, which helps to chemically define the toxin pharmacophore, is
likely to be useful for insecticide design even in the absence of specific information about the target.
The near wild-type activity of a Y31F mutant (see Table I) indicates that Tyr31 interacts with the target
primarily via its aromatic ring and not the hydroxyl group. The much reduced activity of the R8E mutant
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negatively charged group on the target. If Arg8 inserts into the pore of a KcsA-like K+ channel (47), the
complementary charge could be provided by acidic residues lining the external entrance to the pore and/or
the polarized oxygen atoms of backbone carbonyl groups that line the selectivity filter and are oriented in
order to coordinate and stabilize cations (47). The way in which the vicinal disulfide interacts with the toxin
target remains enigmatic. However, along with Ile2, it may simply form an apolar patch (colored orange in
Fig. 5A) that interacts with hydrophobic residues on the target. Consistent with this hypothesis, disruption of
the hydrophobic patch by mutation of the spatially proximal Ala12 to Glu caused an 11-fold drop in
insecticidal potency (see Table I). Additional mutations of the vicinal disulfide residues might help to better
define the role of this structural feature in toxin binding and activity.
In summary, we have developed a recombinant expression system for one of the Janus-faced atracotoxins
and undertaken a comprehensive site-directed mutagenesis study in order to elucidate the key functional
residues. This has provided us with the first complete view of the bioactive surface of a spider toxin. We
have shown that the J-ACTX pharmacophore is relatively small, and localized to a single face of the toxin.
The data provide a solid framework for the rational design of novel insecticides based on the Janus-faced
atracotoxins, as well as clues to the likely target of these toxins.
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 FIGURE LEGENDS
Figure 1: Primary structures of the Janus-faced atracotoxins. Comparison of the primary structures of
the Janus-faced atracotoxins (J-ACTXs) isolated from the funnel-web spider Hadronyche versuta. Identities
are shaded gray and the four disulfide bridges are indicated by solid lines below the sequences. The
sequence numbering at the top of the figure refers to J-ACTX-Hv1c. The key functional residues identified
in this study are indicated by the arrowheads.
Figure 2: Construction of a synthetic gene for J-ACTX-Hv1c. A synthetic gene encoding J-ACTX-Hv1c,
with codons optimized for maximal expression in E. coli, was constructed in two steps. In Step 1, the
complementary overlapping oligonucleotides J-Hv1c-1, J-Hv1c-2, J-Hv1c-3 and J-Hv1c-R were annealed
and extended with Pfu polymerase. In Step 2, the entire coding sequence was PCR amplified using the
primers J-Hv1c-F and J-Hv1c-R, which endoded 5’-BamH1 and 3’-EcoRI sites, respectively, for directional
cloning into BamHI/EcoRI-digested pGEX-2T. See text for details.
Figure 3: Purification and characterization of recombinant J-ACTX-Hv1c. (A) SDS-polyacrylamide
gel illustrating the expression and affinity purification of J-ACTX-Hv1c. Lanes 1 and 2, soluble and
insoluble fractions, respectively, resulting from centrifugation of E. coli BL21/pFM1 lysate; lane 3, eluate
obtained from application of soluble lysate fraction to GSH-sepharose affinity column; lane  4, GSH-sepharose
beads after washing with buffer, showing quantitative extraction of the 30.1 kDa GST-toxin fusion protein
(marked with an arrow) from the cell lysate; lane 5, GSH-sepharose beads after incubation with thrombin
and elution of the liberated toxin with buffer. The disappearance of the GST-toxin band and appearance of a
GST band (marked with an arrow) indicates that the proteolytic cleavage has gone to completion. (B)
rpHPLC purification of recombinant J-ACTX-Hv1c. The major peak, which corresponds to correctly folded
recombinant toxin, had almost identical retention time to that of native J-ACTX-Hv1c (not shown) which
was purified from venom as described previously (12). The early-eluting minor peaks correspond to misfolded
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bar below the major peak denotes the toxin fraction that was used for subsequent structure-function analyses.
(C) Dose-response curves resulting from injection of native (WT, ?) or various mutant recombinant toxins
(N27A, ?; V29A, ?; R8A, ?; P9A, ?) into M. domestica. Each data point is the mean of two independent
experiments. The solid line represents the fit to the data that was used to extract the LD50 values shown in
Table I.
Figure 4: Structural analysis of native and mutant recombinant toxins. Comparison of the far-UV CD
spectrum of recombinant J-ACTX-Hv1c (WT, ?) with (A) A6S (?) and Y31A (?) mutants; (B) A12E (?),
S21A (?), V29A (?), and K34A (∇)  mutants; (C) P9A (?) and R33A (?) mutants.
Figure 5: The bioactive surface of J-ACTX-Hv1c. (A) Molecular surface of J-ACTX-Hv1c (PDB file
1DL0) illustrating the key functional residues identified using site-directed mutagenesis. These residues
form two closely apposed patches (orange and red) on one face of the toxin. (B) Side-on view of the
J-ACTX-Hv1c pharmacophore illustrating the alignment of key functional residues along a single face of
the toxin. Note the location of Ile2 and Val29 at the periphery of the bioactive surface. (C) Superposition of
the sidechains of the functionally critical Arg8 and Tyr31 residues of J-ACTX-Hv1c (green) on the Lys–Tyr/Phe
diad of the K+ channel blockers agitoxin2 (blue; PDB file 1AGT) and BgK (red; PDB file 1BGK). The
three-dimensional folds of these toxins are very different and thus, for the sake of clarity, only the backbone
of J-ACTX-Hv1c is shown (thin green tube, except for arrows representing the two β-strands).
24
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     Table I: Insecticidal activity of recombinant J-ACTX-Hv1c and various point mutants
Toxin Foldeda LD50 (pmol g
–1)b Fold reductionc
rJ-ACTX-Hv1c ++      320 + 20d     1.0
I2A ++    2100 + 200     6.6
T4A ++    1200 + 100     3.8
A6S —            n.d.     n.d.
D7A ++      340 + 20     1.1
R8A ++ 31,200 +  1600   98
R8E ++ 86,300 +  5800 270
P9A + 86,000 +  4300 269
A11S ++      320 + 20     1.0
A12S ++      460 + 30     1.4
A12E ++   3,700 + 200   12
C13S,C14S ++e 135,400 ± 6,800 423
P15A ++      550 + 50     1.7
P18A ++      290 + 20     0.9
T20A ++      380 + 20     1.2
S21A ++      350 + 20     1.1
K23A ++      460 + 30     1.4
A24S ++      370 + 20     1.2
E25A ++     400 + 20     1.3
S26A ++      350 + 20     1.1
N27A ++   1,100 + 100     3.4
G28A ++      970 + 50     3.0
V29A ++   4,200 + 200   13
S30A ++   1,610 + 80     5.0
Y31A ++ 51,700 + 2600 162
Y31F ++      590 + 30     1.8
R33A +   3,500 + 200   11
R33H ++      440 + 50     1.4
R33L ++      570 + 30     1.8
K34A ++      380 + 20     1.2
D35A ++      330 + 20     1.0
a As determined using CD spectroscopy. ++  = native fold, +  = small structural perturbation, – = unfolded.
b LD50 determined by injection into M. domestica.
c Fold reduction in toxicity calculated as LD50 mutant / LD50 unmutated recombinant toxin.
d Errors were estimated as 5% of the LD50 or the standard error from the dose-response curves, whichever
was largest.
e Determined previously using NMR spectroscopy (12).
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